Patients taking compounded weight loss drugs from online pharmacies share what it's like — and they couldn't go the ...

The Australian Competition and Consumer Commission (ACCC) issued a warning on Thursday, highlighting the potential for a gas ...

Hims & Hers stock price has imploded this year, erasing some of the gains made in 2024 when it became one of the ...

We recently published a list of AI Stocks Dominate Wednesday’s 10 Worst Performers. In this article, we are going to take a ...

There is truly nothing new under the sun, but a few recently launched campaigns prove that there are fresh ways to say the ...

Among today’s creative highlights, Frida offers a nutritious treat with breast milk ice cream; Major League Baseball leans ...

Hims & Hers Health (HIMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Hims & Hers Health stock corrected after earnings because of the outlook on its key GLP-1 medication. See why I rate HIMS a ...

Integra LifeSciences Holdings Corporation IART is successfully broadening its international footprint through certain key developments on the overseas front. The company also sees healthy demand for ...

Billions of dollars in annual revenue and the health of millions of patients are at stake in a drug industry battle over who ...

Discover how Meta's India, WhatsApp, and AI businesses are poised to drive growth and boost cash flows, shaping the company's ...

We recently published a list of Why These 15 Defensive Stocks Are Surging In 2025. In this article, we are going to take a ...